Computational drug repurposing identifies flavoxate as a novel NLRP3 inflammasome inhibitor for Alzheimer’s disease therapy
In Silico Pharmacology · 31.07.2026 · 14 (2)
DOI: 10.1007/s40203-026-00696-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Silico Pharmacology, online erschienen am 31.07.2026. Verfasst von Gajendra Choudhary und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, PGIMER, Institute of Medical Education and Research, Chandigarh, India. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, PGIMER, Institute of Medical Education and Research, Chandigarh, India.
- Department of Biotechnology and Food Technology, Chandigarh University, Mohali, India.
- Department of Biochemistry, PGIMER, Institute of Medical Education and Research, Chandigarh, India.
Zitieren
APA
Choudhary, G., Rajput, H., Kulkarni, R., Siddiqui, H., Prakash, A., & Medhi, B. (2026). Computational drug repurposing identifies flavoxate as a novel NLRP3 inflammasome inhibitor for Alzheimer’s disease therapy. In Silico Pharmacology, 14(2). https://doi.org/10.1007/s40203-026-00696-3
Vancouver
Choudhary G, Rajput H, Kulkarni R, Siddiqui H, Prakash A, Medhi B. Computational drug repurposing identifies flavoxate as a novel NLRP3 inflammasome inhibitor for Alzheimer’s disease therapy. In Silico Pharmacology. 2026;14(2). doi:10.1007/s40203-026-00696-3
BibTeX
@article{Choudhary2026,
author = {Choudhary, Gajendra and Rajput, Harshita and Kulkarni, Rutweek and Siddiqui, Hadiya and Prakash, Ajay and Medhi, Bikash},
title = {Computational drug repurposing identifies flavoxate as a novel NLRP3 inflammasome inhibitor for Alzheimer’s disease therapy},
journal = {In Silico Pharmacology},
year = {2026},
volume = {14},
number = {2},
doi = {10.1007/s40203-026-00696-3}
}
EUVIMED